ArticleOncotarget2017

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.

Itaru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.